CoChat

Animal Models of Rheumatoid Arthritis (I): Pristane-Induced Arthritis in the Rat

Open access
Tuncel, Jonatan, Haag, Sabrina, Hoffmann, Markus H., Yau, Anthony C. Y., Hultqvist, Malin, Olofsson, Peter, Bäcklund, Johan, Nandakumar, Kutty Selva, Weidner, Daniela, Fischer, Anita, Leichsenring, Anna, Lange, Franziska, Haase, Claus, Lu, Shemin, Gulko, Percio S., Steiner, Günter, Holmdahl, Rikard · 2016 · PLOS ONE
Cited by 81

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND: To facilitate the development of therapies for rheumatoid arthritis (RA), the Innovative Medicines Initiative BTCure has combined the experience from several laboratories worldwide to establish a series of protocols for different animal models of arthritis that reflect the pathogenesis of RA. Here, we describe chronic pristane-induced arthritis (PIA) model in DA rats, and provide detailed instructions to set up and evaluate the model and for reporting data. METHODS: We optimized dose of pristane and immunization procedures and determined the effect of age, gender, and housing conditions. We further assessed cage-effects, reproducibility, and frequency of chronic arthritis, disease markers, and efficacy of standard and novel therapies. RESULTS: Out of 271 rats, 99.6% developed arthritis after pristane-administration. Mean values for day of onset, day of maximum arthritis severity and maximum clinical scores were 11.8±2.0 days, 20.3±5.1 days and 34.2±11 points on a 60-point scale, respectively. The mean frequency of chronic arthritis was 86% but approached 100% in long-term experiments over 110 days. Pristane was arthritogenic even at 5 microliters dose but needed to be administrated intradermally to induce robust disease with minimal variation. The development of arthritis was age-dependent but independent of gender and whether the rats were housed in conventional or barrier facilities. PIA correlated well with weight loss and acute phase reactants, and was ameliorated by etanercept, dexamethasone, cyclosporine A and fingolimod treatment. CONCLUSIONS: PIA has high incidence and excellent reproducibility. The chronic relapsing-remitting disease and limited systemic manifestations make it more suitable than adjuvant arthritis for long-term studies of joint-inflammation and screening and validation of new therapeutics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0155936

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 81

Metadata

Authors
Tuncel, J., Haag, S., Hoffmann, M. H., Yau, A. C. Y., Hultqvist, M., Olofsson, P., Bäcklund, J., Nandakumar, K. S., Weidner, D., Fischer, A., Leichsenring, A., Lange, F., Haase, C., Lu, S., Gulko, P. S., Steiner, G., & Holmdahl, R.
Venue
PLOS ONE
Published
2016-05-26
Volume
11
Issue
5
Pages
e0155936
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2397788451
Cited by
81
References
4
FWCI
9.03
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Animal Models of Rheumatoid Arthritis (I): Pristane-Induced Arthritis in the Rat. https://app.cochat.ai/papers/10.1371/journal.pone.0155936
The paper
Tuncel, J., Haag, S., Hoffmann, M. H., Yau, A. C. Y., Hultqvist, M., Olofsson, P., Bäcklund, J., Nandakumar, K. S., Weidner, D., Fischer, A., Leichsenring, A., Lange, F., Haase, C., Lu, S., Gulko, P. S., Steiner, G., & Holmdahl, R. (2016). Animal Models of Rheumatoid Arthritis (I): Pristane-Induced Arthritis in the Rat. PLOS ONE. https://doi.org/10.1371/journal.pone.0155936

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.